fetal-derived neural stem cells
Cell therapyexperimental
Clinical trial activity
3 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 17, 2017 (NCT03269071)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04812431 | Phase 1/Phase 2 (Phase 2) | Sep 30, 2021 | Linical Co., Ltd., S.Biomedics Co., Ltd., Yonsei University |
| NCT04631406 | Phase 1/Phase 2 (Phase 2) | Jan 4, 2021 | California Institute for Regenerative Medicine (CIRM), Stanford University |
| NCT03269071 | Phase 1 | May 17, 2017 | Fondazione Italiana Sclerosi Multipla, Vita-Salute University of Milano. Italy |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| California Institute for Regenerative Medicine (CIRM) | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Fondazione Italiana Sclerosi Multipla | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Linical Co., Ltd. | For profit | 1 | 0 | 1 | 2021 |
| S.Biomedics Co., Ltd. | For profit | 1 | 1 | 1 | 2021 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Vita-Salute University of Milano. Italy | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Yonsei University | Academic/Hospital | 1 | 0 | 1 | 2021 |
7 organizations
Page 1 / 1